Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 3735452, 12 pages
http://dx.doi.org/10.1155/2016/3735452
Research Article

Mesenchymal Stem Cell-Educated Macrophages Ameliorate LPS-Induced Systemic Response

1The Children’s Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China
2Shaoxing Second Hospital, Shaoxing, Zhejiang 312000, China
3The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China

Received 1 January 2016; Revised 23 May 2016; Accepted 6 June 2016

Academic Editor: Anshu Agrawal

Copyright © 2016 Yaoqin Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Xu, C. R. Woods, A. L. Mora et al., “Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 293, no. 1, pp. L131–L141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Rojas, J. Xu, C. R. Woods et al., “Bone marrow-derived mesenchymal stem cells in repair of the injured lung,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 2, pp. 145–152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. H. J. Mei, S. D. McCarter, Y. Deng, C. H. Parker, W. C. Liles, and D. J. Stewart, “Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin,” PLoS Medicine, vol. 4, no. 9, article e269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Ortiz, F. Gambelli, C. McBride et al., “Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8407–8411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Gupta, X. Su, B. Popov, W. L. Jae, V. Serikov, and M. A. Matthay, “Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice,” Journal of Immunology, vol. 179, no. 3, pp. 1855–1863, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-K. Sun, C.-H. Yen, Y.-C. Lin et al., “Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model,” Journal of Translational Medicine, vol. 9, article 118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Martínez-González, O. Roca, J. R. Masclans et al., “Human mesenchymal stem cells overexpressing the IL-33 antagonist soluble IL-1 receptor-like-1 attenuate endotoxin-induced acute lung injury,” American Journal of Respiratory Cell and Molecular Biology, vol. 49, no. 4, pp. 552–562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M.-H. Chien, M.-Y. Bien, C.-C. Ku et al., “Systemic human orbital fat-derived stem/stromal cell transplantation ameliorates acute inflammation in lipopolysaccharide-induced acute lung injury,” Critical Care Medicine, vol. 40, no. 4, pp. 1245–1253, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Chen, C. Li, X. Gao et al., “Keratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice,” PLoS ONE, vol. 8, no. 12, Article ID e83303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Németh, A. Leelahavanichkul, P. S. T. Yuen et al., “Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production,” Nature Medicine, vol. 15, no. 1, pp. 42–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. W. Lee, A. Krasnodembskaya, D. H. McKenna, Y. Song, J. Abbott, and M. A. Matthay, “Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 7, pp. 751–760, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. D. G. Phinney, M. Di Giuseppe, J. Njah et al., “Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs,” Nature Communications, vol. 6, article 8472, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Herold, K. Mayer, and J. Lohmeyer, “Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair,” Frontiers in Immunology, vol. 2, article 65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Salgame, G. S. Yap, and W. C. Gause, “Effect of helminth-induced immunity on infections with microbial pathogens,” Nature Immunology, vol. 14, no. 11, pp. 1118–1126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Kim and P. Hematti, “Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages,” Experimental Hematology, vol. 37, no. 12, pp. 1445–1453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Eggenhofer and M. J. Hoogduijn, “Mesenchymal stem cell-educated macrophages,” Transplantation Research, vol. 1, article 12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Anderson, L. Souza-Moreira, M. Morell et al., “Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis,” Gut, vol. 62, no. 8, pp. 1131–1141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Geng, L. Zhang, B. Fu et al., “Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages,” Stem Cell Research & Therapy, vol. 5, article 80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. V. M. Ranieri, G. D. Rubenfeld, B. T. Thompson et al., “Acute respiratory distress syndrome: the Berlin definition,” The Journal of the American Medical Association, vol. 307, no. 23, pp. 2526–2533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Zheng, L. Huang, H. Tong et al., “Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study,” Respiratory Research, vol. 15, article 39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. B. Everhart, W. Han, T. P. Sherrill et al., “Duration and intensity of NF-κB activity determine the severity of endotoxin-induced acute lung injury,” Journal of Immunology, vol. 176, no. 8, pp. 4995–5005, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Zhang, S. D. Danchuk, K. M. Imhof et al., “Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury,” Stem Cell Research & Therapy, vol. 4, article 13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, W. Sime, M. Juhas, and A. Sjölander, “Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration,” European Journal of Cancer, vol. 49, no. 15, pp. 3320–3334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. González, E. Gonzalez-Rey, L. Rico, D. Büscher, and M. Delgado, “Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses,” Gastroenterology, vol. 136, no. 3, pp. 978–989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Maggini, G. Mirkin, I. Bognanni et al., “Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile,” PLoS ONE, vol. 5, no. 2, Article ID e9252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Q.-Z. Zhang, W.-R. Su, S.-H. Shi et al., “Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing,” Stem Cells, vol. 28, no. 10, pp. 1856–1868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Barminko, J. H. Kim, S. Otsuka et al., “Encapsulated mesenchymal stromal cells for in vivo transplantation,” Biotechnology and Bioengineering, vol. 108, no. 11, pp. 2747–2758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Del Papa, P. Sportoletti, D. Cecchini et al., “Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction,” European Journal of Immunology, vol. 43, no. 1, pp. 182–187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Selmani, A. Naji, I. Zidi et al., “Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25highFOXP3+ regulatory T cells,” Stem Cells, vol. 26, no. 1, pp. 212–222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. E. B. Okeke, I. Okwor, Z. Mou, P. Jia, and J. E. Uzonna, “CD4+CD25+ regulatory T cells attenuate lipopolysaccharide-induced systemic inflammatory responses and promotes survival in murine Escherichia coli infection,” Shock, vol. 40, no. 1, pp. 65–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Ionescu, R. N. Byrne, T. van Haaften et al., “Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 303, no. 11, pp. L967–L977, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Le Blanc, F. Frassoni, L. Ball et al., “Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study,” The Lancet, vol. 371, no. 9624, pp. 1579–1586, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Hare, J. H. Traverse, T. D. Henry et al., “A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277–2286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. F. de la Portilla, F. Alba, D. García-Olmo, J. M. Herrerías, F. X. González, and A. Galindo, “Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial,” International Journal of Colorectal Disease, vol. 28, no. 3, pp. 313–323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. O. E. Simonson, D. Mougiakakos, N. Heldring et al., “In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome,” Stem Cells Translational Medicine, vol. 4, no. 10, pp. 1199–1213, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Miura, Y. Miura, H. M. Padilla-Nash et al., “Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation,” Stem Cells, vol. 24, no. 4, pp. 1095–1103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. A. Hutchinson, P. Riquelme, B. Sawitzki et al., “Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients,” Journal of Immunology, vol. 187, no. 5, pp. 2072–2078, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Zuloff-Shani, A. Adunsky, A. Even-Zahav et al., “Hard to heal pressure ulcers (stage III-IV): efficacy of injected activated macrophage suspension (AMS) as compared with standard of care (SOC) treatment controlled trial,” Archives of Gerontology and Geriatrics, vol. 51, no. 3, pp. 268–272, 2010. View at Publisher · View at Google Scholar · View at Scopus